Articles

doi: 10.1007/s00277-012-1538-7

Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral blood adversely affects survival

Santamaria, Carlos; Ramos, Fernando; Puig, Noemi; Barragan, Eva; de Paz, Raquel; Pedro, Carme; Insunza, Andres; Tormo, Mar; del Canizo, Consuelo; Diez-Campelo, Maria; Xicoy, Blanca; Salido, Eduardo; Sanchez del Real, Javier; Hernandez, Montserrat; Chillon, Carmen; Sanz, Guillermo F.; Garcia-Sanz, Ramon; San Miguel, Jesus F.; Gonzalez, Marcos

doi: 10.1016/j.leukres.2011.10.025

The degree of neutropenia has a prognostic impact in low risk myelodysplastic syndrome

Cordoba, I.; Gonzalez-Porras, J. R.; Such, E.; Nomdedeu, B.; Luno, E.; de Paz, R.; Carbonell, F.; Vallespi, T.; Ardanaz, M.; Ramos, F.; Marco, V.; Bonanad, S.; Sanchez-Barba, M.; Costa, D.; Bernal, T.; Sanz, G. F.; Canizo, M. C.

doi: 10.1111/bjh.12035

Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromes

Saumell, Silvia; Florensa, Lourdes; Luno, Elisa; Sanzo, Carmen; Canizo, Consuelo; Hernandez, Jesus M.; Cervera, Jose; Gallart, Miguel A.; Carbonell, Felix; Collado, Rosa; Arenillas, Leonor; Pedro, Carme; Bargay, Joan; Nomdedeu, Benet; Xicoy, Blanca; Vallespi, Teresa; Raya, Jose M.; Belloch, Luis; Sanz, Guillermo F.; Sole, Francesc

doi: 10.1182/blood-2012-03-420489

Revised International Prognostic Scoring System for Myelodysplastic Syndromes

Greenberg, Peter L.; Tuechler, Heinz; Schanz, Julie; Sanz, Guillermo; Garcia-Manero, Guillermo; Sole, Francesc; Bennett, John M.; Bowen, David; Fenaux, Pierre; Dreyfus, Francois; Kantarjian, Hagop; Kuendgen, Andrea; Levis, Alessandro; Malcovati, Luca; Cazzola, Mario; Cermak, Jaroslav; Fonatsch, Christa; Le Beau, Michelle M.; Slovak, Marilyn L.; Krieger, Otto; Luebbert, Michael; Maciejewski, Jaroslaw; Magalhaes, Silvia M. M.; Miyazaki, Yasushi; Pfeilstoecker, Michael; Sekeres, Mikkael; Sperr, Wolfgang R.; Stauder, Reinhard; Tauro, Sudhir; Valent, Peter; Vallespi, Teresa; van de Loosdrecht, Arjan A.; Germing, Ulrich; Haase, Detlef

doi: 10.1016/j.bbmt.2011.04.009

Pretransplantation Liver Function Impacts on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: A Study of 455 Patients

Barba P, Piñana JL, Fernández-Avilés F, Perez-Simón JA, Martino R, López-Guerrero E, Valcárcel D, Rovira M, Novelli S, Campos-Varela I, López-Anglada L, Vidal X, López Corral L, Carreras E, Sierra J

doi: 10.1016/j.radmeas.2011.05.009

Assessment in vitro of radioprotective efficacy of curcumin and resveratrol

Natividad Sebastià, Alegria Montoro, Amparo Montoro, Miguel Almonacid, Juan Ignacio Villaescusa, José Cervera ,Esperanza Such Ma Angeles Silla, Jose Miguel Soriano

Romiplostim: A new chance in ITP | [Romiplostim: Una nueva oportunidad en PTI]

Jordán De Luna, M.C., Romá Sánchez, E., Jarque Ramos, I., Poveda Andrés, J.L

doi: 10.1038/bmt.2010.177

Reduction of infection-related mortality after allogeneic PBSCT from HLA-identical siblings: Longitudinal analysis from 1994 to 2008 at a single institution

Martino R, Kerguelen A, Valcárcel D, Sureda A, Fachini L, Piñana JL, Briones J, Delgado J, Brunet S, Sierra J

doi: 10.1007/s12185-011-0825-8

Vitamin B12 deficiency, hyperhomocysteinemia and thrombosis: A case and control study

Remacha AF, Souto JC, Piñana JL, Sardà MP, Queraltó JM, Martí-Fabregas J, García-Moll X, Férnandez C, Rodriguez A, Cuesta J

doi: 10.1016/S0213-005X(11)70009-X

Is micafungin useful in the prophylaxis of invasive fungal disease in hematological patients? | [¿es útil el uso de micafungina en la profilaxis de la enfermedad fúngica invasora en el paciente hematológico?]

Salavert M, Jarque I

doi: 10.1586/ehm.10.77

Incidence of cytomegalovirus infection and disease in patients with lymphoproliferative disorders treated with alemtuzumab

Vallejo C, Ríos E, de la Serna J, Jarque I, Ferrá C, Sánchez-Godoy P, Solano C, de la Cámara R, Rosell AI, Varela R, García MD, González-Barca E, López J, Pérez E, Ferrer S, Casado LF, Vázquez L, Villalón L, García-Marco JA

doi: 10.1177/2040620710396752

Long-Term Results of Fludarabine/Melphalan as a Reduced-Intensity Conditioning Regimen in Mantle Cell Lymphoma: The GELTAMO Experience

Cruz JG, Martino R, Balsalobre P, Heras I, Piñana JL, Serrano D, de la Serna J, Tomás JF, Díez-Martíin JL, Caballero D

doi: 10.1111/j.1537-2995.2010.02936.x

Viable hematopoietic progenitor cells in frozen femoral heads from living donors for orthopedic surgery

Mirabet V, Roig RJ, Solves P

doi: 10.1016/B978-0-12-380928-5.10026-0

Stem Cell Banking

Mirabet V, Solves P

doi: 10.3851/IMP1858

Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients

Ruiz-Camps I, Len O, de la Cámara R, Gurguí M, Martino R, Jarque I, Barrenetxea C, Díaz de Heredia C, Batlle M, Rovira M, de la Torre J, Torres A, Aguilar M, Espigado I, Martín-Dávila P, Bou G, Borrell N, Aguado JM, Pahissa A

Eculizumab in paroxysmal nocturnal haemoglobinuria

Escudero-Jimenez, A., Esteban-Mensua, M.J., Lopez, E., Jarque-Ramos, I., Borrell-Garcia, C., Poveda-Andres, J.L.

The differentiation syndrome in patients with acute promyelocytic leukemia: experience of the pethema group and review of the literature

Montesinos P, Sanz MA

The European LeukemiaNet: achievements and perspectives

Hehlmann R, Grimwade D, Simonsson B, Apperley J, Baccarani M, Barbui T, Barosi G, Bassan R, Béné MC, Berger U, Büchner T, Burnett A, Cross NCP, de Witte TJM, Döhner H, Dombret H, Einsele H, Engelich G, Foà R, Fonatsch C, Gökbuget N, Gluckman E, Gratwohl A, Guilhot F, Haferlach C, Haferlach T, Hallek M, Hasford J, Hochhaus A, Hoelzer D, Kiladjian J-J, Labar B, Ljungman P, Mansmann U, Niederwieser D, Ossenkoppele G, Ribera JM, Rieder H, Serve H, Schrotz-King P, Sanz MA, Saussele S, European LeukemiaNet

Treatment of multiple myeloma in the elderly: realities and hopes

la Rubia de J, Sanz MA

Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q

Mallo M, Cervera J, Schanz J, Such E, García-Manero G, Luño E, Steidl C, Espinet B, Vallespí T, Germing U, Blum S, Ohyashiki K, Grau J, Pfeilstöcker M, Hernández JM, Noesslinger T, Giagounidis A, Aul C, Calasanz MJ, Martín ML, Valent P, Collado R, Haferlach C, Fonatsch C, Lübbert M, Stauder R, Hildebrandt B, Krieger O, Pedro C, Arenillas L, Sanz MA, Valencia A, Florensa L, Sanz GF, Haase D, Solé F

Analysis of EQ-5D scores from two phase 3 clinical trials of romiplostim in the treatment of immune thrombocytopenia (ITP)

Sanz MA, Aledort L, Mathias SD, Wang X, Isitt JJ

A novel NUP98/RARG gene fusion in acute myeloid leukemia resembling acute promyelocytic leukemia

Such E, Cervera J, Valencia A, Barragán E, Ibáñez M, Luna I, Fuster Ó, Perez-Sirvent ML, Senent L, Sempere A, Martínez J, Martín-Aragonés G, Sanz MA

Early death in patients with acute promyelocytic leukemia. Proceedings from a live roundtable at the 2010 American Society of Hematology Annual Meeting, December 4?7, 2010, Orlando, Florida

Tallman MS, Lo-Coco F, Kwaan HC, Sanz MA, Gore SD

Modern approaches to treating acute promyelocytic leukemia

Sanz MA, Lo-Coco F

Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens

Montesinos P, Rayón C, Vellenga E, Brunet S, González J, González M, Holowiecka A, Esteve J, Bergua J, González JD, Rivas C, Tormo M, Rubio V, Bueno J, Manso F, Milone G, la Serna de J, Pérez I, Pérez-Encinas M, Krsnik I, Ribera JM, Escoda L, Löwenberg B, Sanz MA, PETHEMA, HOVON Groups

Update on bacteraemia in oncology and hematology

Fortún J, Sanz MA, Madero L, López J, la Torre de J, Jarque I, Vallejo C

Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes

Hasan SK, Buttari F, Ottone T, Voso MT, Hohaus S, Marasco E, Mantovani V, Garagnani P, Sanz MA, Cicconi L, Bernardi G, Centonze D, Lo-Coco F

Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse

Levis M, Ravandi F, Wang ES, Baer MR, Perl A, Coutre S, Erba H, Stuart RK, Baccarani M, Cripe LD, Tallman MS, Meloni G, Godley LA, Langston AA, Amadori S, Lewis ID, Nagler A, Stone R, Yee K, Advani A, Douer D, Wiktor-Jedrzejczak W, Juliusson G, Litzow MR, Petersdorf S, Sanz M, Kantarjian HM, Sato T, Tremmel L, Bensen-Kennedy DM, Small D, Smith BD

Presenting features and treatment outcome of acute promyelocytic leukemia arising after multiple sclerosis

Ammatuna E, Montesinos P, Hasan SK, Ramadan SM, Esteve J, Hubmann M, Pagoni M, Grimwade D, Sanz MA, Lo-Coco F

Aberrant methylation of tumor suppressor genes in patients with refractory anemia with ring sideroblasts

Valencia A, Cervera J, Such E, Ibáñez M, Gómez I, Luna I, Senent L, Oltra S, Sanz MA, Sanz GF

[Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update]

Fortún J, Carratalá J, Gavaldá J, Lizasoain M, Salavert-Lleti M, la Cámara de R, Borges M, Cervera C, Garnacho J, Lassaleta Á, Lumbreras C, Sanz MA, Ramos JT, Torre-Cisneros J, Aguado JM, Cuenca-Estrella M, Grupo de Estudio de Micología Médica de la SEIMC (GEMICOMED)

Whole-genome sequencing and acute promyelocytic leukemia

Lo-Coco F, Sanz MA

Central nervous system involvement at first relapse in patients with acute myeloid leukemia

Martínez-Cuadrón D, Montesinos P, Pérez-Sirvent M, Avaria A, Cordón L, Rodríguez-Veiga R, Martín G, Sanz J, Martínez J, Sanz MA

Reduced corticosteroid use in adult patients with primary immune thrombocytopenia receiving romiplostim

Michel M, Boekhorst te PAW, Janssens A, Pabinger-Fasching I, Sanz MA, Nie K, Kreuzbauer G

Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy

Barragán E, Montesinos P, Camos M, González M, Calasanz MJ, Román-Gómez J, Gómez-Casares MT, Ayala R, López J, Fuster Ó, Colomer D, Chillón C, Larrayoz MJ, Sánchez-Godoy P, González-Campos J, Manso F, Amador ML, Vellenga E, Löwenberg B, Sanz MA, PETHEMA, HOVON Groups

Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia

Vázquez I, Maicas M, Cervera J, Agirre X, Marin-Béjar O, Marcotegui N, Vicente C, Lahortiga I, Gomez-Benito M, Carranza C, Valencia A, Brunet S, Lumbreras E, Prosper F, Gómez-Casares MT, Hernández-Rivas JM, Calasanz MJ, Sanz MA, Sierra J, Odero MD

CYP2C8 gene polymorphism and bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma

Such E, Cervera J, Terpos E, Bagán JV, Avaria A, Gómez I, Margaix M, Ibáñez M, Luna I, Cordón L, Roig M, Sanz MA, Dimopoulos MA, la Rubia de J

doi: 10.1182/blood-2011-01-330126

A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q

Fenaux, Pierre; Giagounidis, Aristoteles; Selleslag, Dominik; Beyne-Rauzy, Odile; Mufti, Ghulam; Mittelman, Moshe; Muus, Petra; Boekhorst, Peter Te; Sanz, Guillermo; del Canizo, Consuelo; Guerci-Bresler, Agnes; Nilsson, Lars; Platzbecker, Uwe; Luebbert, Michael; Quesnel, Bruno; Cazzola, Mario; Ganser, Arnold; Bowen, David; Schlegelberger, Brigitte; Aul, Carlo; Knight, Robert; Francis, John; Fu, Tommy; Hellstrom-Lindberg, Eva

doi: 10.1016/j.leukres.2011.01.003

Clinical impact of the clone size in MDS cases with monosomy 7 or 7q deletion, trisomy 8, 20q deletion and loss of Y chromosome

Mallo, Mar; Luno, Elisa; Sanzo, Carmen; Cervera, Jose; Haase, Detlef; Schanze, Julie; Garcia-Manero, Guillermo; del Canizo, Consuelo; Sanz, Guillermo F.; Sole, Francesc

doi: 10.1002/cncr.25774

Continued Azacitidine Therapy Beyond Time of First Response Improves Quality of Response in Patients With Higher-Risk Myelodysplastic Syndromes

Silverman, Lewis R.; Fenaux, Pierre; Mufti, Ghulam J.; Santini, Valeria; Hellstrom-Lindberg, Eva; Gattermann, Norbert; Sanz, Guillermo; List, Alan F.; Gore, Steven D.; Seymour, John F.

doi: 10.3324/haematol.2010.030957

Cytogenetic risk stratification in chronic myelomonocytic leukemia

Such, Esperanza; Cervera, Jose; Costa, Dolors; Sole, Francesc; Vallespi, Teresa; Luno, Elisa; Collado, Rosa; Calasanz, Maria J.; Hernandez-Rivas, Jesus M.; Cigudosa, Juan C.; Nomdedeu, Benet; Mallo, Mar; Carbonell, Felix; Bueno, Javier; Ardanaz, Maria T.; Ramos, Fernando; Tormo, Mar; Sancho-Tello, Reyes; del Canizo, Consuelo; Gomez, Valle; Marco, Victor; Xicoy, Blanca; Bonanad, Santiago; Pedro, Carmen; Bernal, Teresa; Sanz, Guillermo F.

doi: 10.1016/S1470-2045(11)70260-1

Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis

Eapen, Mary; Klein, John P.; Sanz, Guillermo F.; Spellman, Stephen; Ruggeri, Annalisa; Anasetti, Claudio; Brown, Maria; Champlin, Richard E.; Garcia-Lopez, Joan; Hattersely, Gareth; Koegler, Gesine; Laughlin, Mary J.; Michel, Gerard; Nabhan, Samir K.; Smith, Franklin O.; Horowitz, Mary M.; Gluckman, Eliane; Rocha, Vanderson

doi: 10.1016/j.bbmt.2010.06.011

Influence of Nucleated Cell Dose on Overall Survival of Unrelated Cord Blood Transplantation for Patients with Severe Acquired Aplastic Anemia: A Study by Eurocord and the Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation

de Latour, Regis Peffault; Purtill, Duncan; Ruggeri, Annalisa; Sanz, Guillermo; Michel, Gerard; Gandemer, Virginie; Maury, Sebastien; Kurtzberg, Joanne; Bonfim, Carmen; Aljurf, Mahmoud; Gluckman, Eliane; Socie, Gerard; Passweg, Jakob; Rocha, Vanderson

doi: 10.1002/cncr.26173

Prognostic impact of severe thrombocytopenia in low-risk myelodysplastic syndrome

Ramon Gonzalez-Porras, Jose; Cordoba, Iris; Such, Esperanza; Nomdedeu, Benet; Vallespi, Teresa; Carbonell, Felix; Luno, Elisa; Ardanaz, Maite; Ramos, Fernando; Pedro, Carme; Gomez, Valle; de Paz, Raquel; Sanchez-Barba, Mercedes; Sanz, Guillermo F.; del Canizo, Consuelo

doi: 10.1016/j.trre.2010.12.002

Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas

Pinazo, Maria-Jesus; Miranda, Blanca; Rodriguez-Villar, Camino; Altclas, Javier; Brunet Serra, Merce; Canas Garcia-Otero, Elias; de Almeida, Eros Antonio; de la Mata Garcia, Manuel; Gascon, Joaquim; Garcia Rodriguez, Magdalena; Manito, Nicolas; Moreno Camacho, Asuncion; Oppenheimer, Federico; Puente Puente, Sabino; Riarte, Adelina; Salas Coronas, Joaquin; Salavert Lleti, Miguel; Sanz, Guillermo F.; Torrico, Faustino; Torrus Tendero, Diego; Ussetti, Piedad; Shikanai-Yasuda, Maria Aparecida

doi: 10.1111/j.1600-0609.2011.01660.x

Response of iron overload to deferasirox in rare transfusion-dependent anaemias: equivalent effects on serum ferritin and labile plasma iron for haemolytic or production anaemias

Porter, John B.; Lin, Kai-Hsin; Beris, Photis; Forni, Gian Luca; Taher, Ali; Habr, Dany; Domokos, Gabor; Roubert, Bernard; Thein, Swee Lay

doi: 10.1038/leu.2010.219

Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT

Robin, M.; Sanz, G. F.; Ionescu, I.; Rio, B.; Sirvent, A.; Renaud, M.; Carreras, E.; Milpied, N.; Mohty, M.; Beguin, Y.; Bordigoni, P.; de Witte, T.; Picardi, A.; Purtill, D.; Gluckman, E.; Kroger, N.; Rocha, V.

doi: 10.2174/157488810793351703

Volume Reduction in Routine Cord Blood Banking

Solves P, Mirabet V, Roig R

doi: 10.3109/10428194.2010.527410.

DEPTOR expression and response to thalidomide: Toward a new therapeutic target in multiple myeloma?

de la Rubia J, Such E.

doi: 10.3324/haematol.2009.017608

Reduced intensity conditioning HLA identical sibling donor allogeneic stem cell transplantation for patients with follicular lymphoma: Long-term follow-up from two prospective multicenter trials

Piñana JL, Martino R, Gayoso J, Sureda A, de la Serna J, Díez-Martín JL, Vazquez L, Arranz R, Tomás JF, Sampol A, Solano C, Delgado J, Sierra J, Caballero D

doi: 10.1007/978-3-642-12173-9_11

Role of de-escalation and combination therapy strategies in the management of invasive fungal infection: A multidisciplinary point of view (Book Chapter)

Zaragoza, R. Pemán, J. Salavert, M. Romá, E. Cantón, E.

doi: 10.1007/s00277-010-0997-y

Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia

Peñalver FJ, Alvarez-Larrán A, Díez-Martin JL, Gallur L, Jarque I, Caballero D, Díaz-Mediavilla J, Bustelos R, Fernández-Aceñero MJ, Cabrera JR

doi: 10.1038/bmt.2009.272

Erratum: Economic evaluation of posaconazole vs fluconazole in the prevention of invasive fungal infections in patients with GVHD following haematopoietic SCT (Bone Marrow Transplantation (2010) 45 (925-932) DOI: 10.1038/bmt.2009.272) De La Cámara, R. J

R de la Cámara, I Jarque, M A Sanz, S Grau, M A Casado, F J Sabater & E Carreras

doi: 10.1007/s10549-009-0680-y

Broad BRCA1 and BRCA2 mutational spectrum and high incidence of recurrent and novel mutations in the eastern Spain population

Esteban Cardeñosa E, Bolufer Gilabert P, de Juan Jimenez I, Palanca Suela S, Barragán González E, Chirivella González I, Segura Huerta A, Guillén Ponce C, Martínez de Dueñas E

doi: 10.1016/j.jacc.2009.08.092

Mesenchymal Stem Cells Provide Better Results Than Hematopoietic Precursors for the Treatment of Myocardial Infarction

Armiñán A, Gandía C, García-Verdugo JM, Lledó E, Trigueros C, Ruiz-Saurí A, Miñana MD, Solves P, Payá R, Montero JA, Sepúlveda P

doi: PMID: 19944434

Paroxismal Nocturnal Hemoglobinuria: New Treatments and General Guidelines for Diagnosis

Morado M, Subirá D, López Rubio M; Grupo Español para el Estudio de Hemoglobinuria Paroxística Nocturna por Citometría de Flujo (Marta Morado, Dolores Subiŕa, José M Bosch, María Angeles Cuadrado, Angelina Lemes, Amparo Sempere, María Belén Vidriales, Montserrat López Rubio ) Hemoglobinuria paroxística nocturna: nuevos tratamientos y recomendaciones generales para su diagnóstico

doi: 10.1038/bmt.2009.362

MTX or mycophenolate mofetil with CsA as GVHD prophylaxis after reduced-intensity conditioning PBSCT from HLA-identical siblings

Piñana JL, Valcárcel D, Fernández-Avilés F, Martino R, Rovira M, Barba P, Martínez C, Brunet S, Sureda A, Carreras E, Sierra J

doi: 10.1016/j.medcli.2009.10.036

Profilaxis antifúngica en pacientes oncohematológicos: revisión de la bibliografía médica y recomendaciones

Cámara R de L, Mensa J, Carreras E, Cuenca-Estrella M, García Rodríguez JA, Gobernado M, Picazo J, Aguado JM, Sanz MA

doi: 10.1007/s10549-009-0316-2

CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers

Palanca Suela S, Esteban Cardeñosa E, Barragán González E, de Juan Jiménez I, Chirivella González I, Segura Huerta A, Guillén Ponce C, Martínez de Dueñas E, Montalar Salcedo J, Castel Sánchez V, Bolufer Gilabert P

doi: 10.1016/j.leukres.2010.03.009

Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study

Gattermann, N., Finelli, C., Della Porta, M., Fenaux, P., Ganser, A., Guerci-Bresler, A., ..., Zweegman, S.

Long-term management of chronic immune thrombocytopenic purpura in adults

Palau J, Jarque I, Sanz MA

DNA methylation profiles and their relationship with cytogenetic status in adult acute myeloid leukemia

Alvarez S, Suela J, Valencia A, Fernández A, Wunderlich M, Agirre X, Prosper F, Martín-Subero JI, Maiques A, Acquadro F, Rodriguez Perales S, Calasanz MJ, Román-Gómez J, Siebert R, Mulloy JC, Cervera J, Sanz MA, Esteller M, Cigudosa JC

Cord blood transplantation from unrelated donors in adults with high-risk acute myeloid leukemia

Sanz J, Sanz MA, Saavedra S, Lorenzo I, Montesinos P, Senent L, Planelles D, Larrea L, Martín G, Palau J, Jarque I, Martínez J, la Rubia de J, Moscardó F, Romero M, Luna I, Montava A, Cañabate S, Sanz GF

International consensus report on the investigation and management of primary immune thrombocytopenia

Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Döhner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnett AK, Dombret H, Fenaux P, Grimwade D, Larson RA, Lo-Coco F, Naoe T, Niederwieser D, Ossenkoppele GJ, Sanz MA, Sierra J, Tallman MS, Löwenberg B, Bloomfield CD, European LeukemiaNet

Epigenetic regulation of the non-canonical Wnt pathway in acute myeloid leukemia

Martín V, Valencia A, Agirre X, Cervera J, San Jose-Eneriz E, Vilas-Zornoza A, Rodriguez-Otero P, Sanz MA, Herrera C, Torres A, Prosper F, Román-Gómez J

Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience

Ades L, Guerci A, Raffoux E, Sanz M, Chevallier P, Lapusan S, Recher C, Thomas X, Rayon C, Castaigne S, Tournilhac O, de Botton S, Ifrah N, Cahn J-Y, Solary E, Gardin C, Fegeux N, Bordessoule D, Ferrant A, Meyer-Monard S, Vey N, Dombret H, Degos L, Chevret S, Fenaux P, for the European APL Group

Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy

Cervera J, Montesinos P, Hernández-Rivas JM, Calasanz MJ, Aventín A, Ferro MT, Luño E, Sánchez J, Vellenga E, Rayón C, Milone G, la Serna de J, Rivas C, González JD, Tormo M, Amutio E, González M, Brunet S, Löwenberg B, Sanz MA

A new reliable fluorescence in situ hybridization method for identifying multiple specific cytogenetic abnormalities in acute myeloid leukemia

Valencia A, Cervera J, Such E, Ibáñez M, Barragán E, Fuster Ó, Bolufer P, Moscardó F, Sanz MA

Open issues on bleeding and thrombosis in acute promyelocytic leukemia

Sanz MA, Montesinos P

Economic evaluation of posaconazole vs fluconazole in the prevention of invasive fungal infections in patients with GVHD following haematopoietic SCT

la Cámara de R, Jarque I, Sanz MA, Grau S, Casado MA, Sabater FJ, Carreras E

Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia: association of DNA breaks with specific DNA motifs at PML and RARA loci

Hasan SK, Ottone T, Schlenk RF, Xiao Y, Wiemels JL, Mitra ME, Bernasconi P, Di Raimondo F, Stanghellini MTL, Marco P, Mays AN, Döhner H, Sanz MA, Amadori S, Grimwade D, Lo-Coco F

Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome

Sanz MA, Montesinos P, Rayón C, Holowiecka A, la Serna de J, Milone G, de Lisa E, Brunet S, Rubio V, Ribera JM, Rivas C, Krsnik I, Bergua J, González J, Díaz-Mediavilla J, Rojas R, Manso F, Ossenkoppele G, González JD, Löwenberg B, PETHEMA and HOVON Groups

Unrelated transplantation for poor-prognosis adult acute lymphoblastic leukemia: long-term outcome analysis and study of the impact of hematopoietic graft source

Ferrá C, Sanz J, la Cámara de R, Sanz G, Bermúdez A, Valcarcel D, Rovira M, Serrano D, Caballero D, Espigado L, Morgades M, Heras I, Solano C, Duarte R, Barrenetxea C, García-Noblejas A, Díez-Martin JL, Iriondo A, Carreras E, Sierra J, Sanz MA, Josep-Maria Ribera, on behalf of GETH Grupo Español de Trasplante Hematopoyético and PETHEMA Programa Español de Tratamiento en Hematología SSOH

Single-Unit Umbilical Cord Blood Transplantation from Unrelated Donors in Adult Patients with Chronic Myelogenous Leukemia

Sanz J, Montesinos P, Saavedra S, Lorenzo I, Senent L, Planelles D, Larrea L, Martín G, Palau J, Jarque I, Martínez J, la Rubia de J, Moscardó F, Martinez D, Gómez I, López M, Sanz MA, Sanz GF

Therapy-Related Myeloid Neoplasms in Patients With Acute Promyelocytic Leukemia Treated With All-Trans-Retinoic Acid and Anthracycline-Based Chemotherapy

Montesinos P, González JD, Gonzalez J, Rayon C, de Lisa E, Amigo ML, Ossenkoppele GJ, Penarrubia MJ, Perez-Encinas M, Bergua J, Debén G, Sayas MJ, La Serna de J, Ribera JM, Bueno J, Milone G, Rivas C, Brunet S, Löwenberg B, Sanz M

High efficacy and low toxicity of APL induction with concurrent idarubicin/ATRA followed by a novel and simplified outpatient post-remission therapy using single doses of idarubicin and intermittent ATRA

Aljurf M, Qurashi Al F, Mohareb Al F, Sahovic E, Sharif Al F, Zahrani Al H, Shanqeeti Al A, Owaidah T, Iqbal A, Zaidi SZA, Nurgat ZA, Sanz M, Chaudhri N

Risk-adapted treatment for low- and intermediate-risk acute promyelocytic leukemia

Sanz MA, Montesinos P

Activity and safety of lenalidomide and dexamethasone in patients with multiple myeloma requiring dialysis: a Spanish multicenter retrospective study

la Rubia de J, Roig M, Ibáñez A, García I, Vera JA, Aguilar C, del Campo R, González N, Martínez R, Palomera L, Picón I, Rodríguez JN, Sanz MA

Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: results of a Spanish multicenter study

la Rubia de J, Moscardó F, Gómez MJ, Guardia R, Rodríguez P, Sebrango A, Zamora C, Debén G, Goterris R, López R, Peña F, Pujol M, Vidaller A, Del Río-Garma J, Sanz MA, Grupo Español de Aféresis

Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group

Tallman MS, Kim HT, Montesinos P, Appelbaum FR, la Serna de J, Bennett JM, Debén G, Bloomfield CD, González J, Feusner JH, González M, Gallagher R, González-San Miguel JD, Larson RA, Milone G, Paietta E, Rayón C, Rowe JM, Rivas C, Schiffer CA, Vellenga E, Shepherd L, Slack JL, Wiernik PH, Willman CL, Sanz MA

doi: 10.1200/JCO.2009.23.8329

Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia

Fenaux, Pierre; Mufti, Ghulam J.; Hellstrom-Lindberg, Eva; Santini, Valeria; Gattermann, Norbert; Germing, Ulrich; Sanz, Guillermo; List, Alan F.; Gore, Steven; Seymour, John F.; Dombret, Herve; Backstrom, Jay; Zimmerman, Linda; McKenzie, David; Beach, C. L.; Silverman, Lewis R.

doi: 10.1016/S1470-2045(10)70127-3

Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis

Eapen, Mary; Rocha, Vanderson; Sanz, Guillermo; Scaradavou, Andromachi; Zhang, Mei-Jie; Arcese, William; Sirvent, Anne; Champlin, Richard E.; Chao, Nelson; Gee, Adrian P.; Isola, Luis; Laughlin, Mary J.; Marks, David I.; Nabhan, Samir; Ruggeri, Annalisa; Soiffer, Robert; Horowitz, Mary M.; Gluckman, Eliane; Wagner, John E.

doi: https://www.ncbi.nlm.nih.gov/pubmed/20683042

Influence on Busilvex (R) Pharmacokinetics of Clonazepam Compared to Previous Phenytoin Historical Data

Carreras, E.; Cahn, J. Y.; Puozzo, C.; Kroeger, N.; Sanz, G.; Buzyn, A.; Bacigalupo, A.; Vernant, J. P.

doi: 10.1007/s00277-009-0794-7

Iron overload and chelation therapy in patients with low-risk myelodysplastic syndromes with transfusion requirements

Remacha, Angel F.; Arrizabalaga, Beatriz; Del Canizo, Consuelo; Sanz, Guillermo; Villegas, Ana

doi: 10.1016/j.leukres.2010.05.021

Practical use of azacitidine in higher-risk myelodysplastic syndromes: An expert panel opinion

Fenaux, Pierre; Bowen, David; Gattermann, Norbert; Hellstrom-Lindberg, Eva; Hofmann, Wolf-Karsten; Pfeilstoecker, Michael; Sanz, Guillermo; Santini, Valeria

doi: 10.1016/j.beha.2010.05.001

Umbilical cord blood transplantation from unrelated donors in adult patients with chronic myeloid leukaemia

Sanz, Jaime; Sanz, Guillermo F.

doi: 10.1038/bmt.2009.78

Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT

R Martino, J L Piñana, R Parody, D Valcarcel, A Sureda, S Brunet, J Briones, J Delgado, F Sánchez, N Rabella, J Sierra

doi: 10.1080/14653240802582109

Reduced-intensity conditioning allogeneic hematopoietic cell transplantation using oral fludarabine as part of the conditioning regimen

Delgado J, Marco A, Moreno E, Piñana JL, Valcarcel D, Martino R, Briones J, Sureda A, Brunet S, Sierra J

doi: 10.1016/j.bbmt.2009.07.013

Early and Late Neurological Complications after Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation

Barba P, Piñana JL, Valcárcel D, Querol L, Martino R, Sureda A, Briones J, Delgado J, Brunet S, Sierra J

doi: 10.1016/j.bbmt.2009.11.008

Comparison of Two Pretransplant Predictive Models and a Flexible HCT-CI Using Different Cut off Points to Determine Low-, Intermediate-, and High-Risk Groups: The Flexible HCT-CI Is the Best Predictor of NRM and OS in a Population of Patients Undergoing allo-RIC

Barba P, Piñana JL, Martino R, Valcárcel D, Amorós A, Sureda A, Briones J, Delgado J, Brunet S, Sierra J

doi: 10.1007/s10561-009-9133-4

Microbiological analysis of cryopreserved human heart valves after storage: A survey of 3 banks in Spain

Villalba R, Mirabet V, Rendal E, González AI, Solves P, Andión C, Gómez Villagrán JL.

doi: 10.1038/bmt.2009.180

Cytomegalovirus infection and disease after reduced intensity conditioning allogeneic stem cell transplantation: Single-centre experience

Piñana JL, Martino R, Barba P, Margall N, Roig MC, Valcárcel D, Sierra J, Rabella N

doi: 10.1159/000232382

Characteristics of Umbilical Cord Blood Units Collected from Preterm Deliveries

Solves P, López M, Mirabet V, Blanquer A, Roig R, Perales A

doi: 10.1097/01.cco.0000357474.66035.9b

Allogeneic stem cell transplantation after reduced-intensity conditioning for acute myeloid leukaemia: Impact of chronic graft-versus-host disease

Valcárcel D, Martino R, Piñana JL, Sierra J

doi: 10.1111/j.1537-2995.2009.02146.x

Chagas disease screening in cord blood donors

Solves P, Parada C, Roig R, Hernández MC, Rodríguez R, Prat I

doi: 10.1007/s10549-008-0073-7

High-resolution melting analysis for rapid screening of BRCA1 and BRCA2 Spanish mutations

de Juan I, Esteban E, Palanca S, Barragán E, Bolufer P

doi: 10.1111/j.1537-2995.2008.01995.x

Presence of meconium-stained amniotic fluid in cesarean deliveries increases the total nucleated cell content of umbilical cord blood units

Solves P, Perales A, Fillol M, Bonilla F, Mirabet V, Roig R

doi: 10.1016/j.bbmt.2008.10.011

Study of Kidney Function Impairment after Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation. A Single-Center Experience

Piñana JL, Valcárcel D, Martino R, Barba P, Moreno E, Sureda A, Vega M, Delgado J, Briones J, Brunet S, Sierra J

doi: 10.3233/CH-2009-1156

Erythrocyte aggregability and AB0 blood groups.

Vayá A, Martínez Triguero M, Ricart A, Plumé G, Solves P, Corella D, Romagnoli M

doi: 10.3109/14653240903253865

A new automatic device for routine cord blood banking: Critical analysis of different volume reduction methodologies

Solves P, Mirabet V, Blanquer A, Delgado-Rosas F, Planelles D, Andrade M, Carbonell-Uberos F, Soler MA, Roig R

doi: 10.1200/JCO.2007.15.8865

Analysis of Risk Factors for Outcomes After Unrelated Cord Blood Transplantation in Adults With Lymphoid Malignancies: A Study by the Eurocord-Netcord and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Rodrigues, Celso A.; Sanz, Guillermo; Brunstein, Claudio G.; Sanz, Jaime; Wagner, John E.; Renaud, Marc; de Lima, Marcos; Cairo, Mitchell S.; Fuerst, Sabine; Rio, Bernard; Dalley, Christopher; Carreras, Enric; Harousseau, Jean-Luc; Mohty, Mohamad; Taveira, Denis; Dreger, Peter; Sureda, Anna; Gluckman, Eliane; Rocha, Vanderson

doi: 10.1016/S1470-2045(09)70003-8

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Fenaux, Pierre; Mufti, Ghulam J.; Hellstrom-Lindberg, Eva; Santini, Valeria; Finelli, Carlo; Giagounidis, Aristoteles; Schoch, Robert; Gattermann, Norbert; Sanz, Guillermo; List, Alan; Gore, Steven D.; Seymour, John F.; Bennett, John M.; Byrd, John; Backstrom, Jay; Zimmerman, Linda; McKenzie, David; Beach, C. L.; Silverman, Lewis R.

doi: 10.1111/j.1399-0039.2009.01378.x

HLA-B*0777 allele differs from B*0707 by a single residue in the antigen binding groove

Balas, A.; Planelles, D.; Sanz, G. F.; Montoro, J. A.; Vicario, J. L.

doi: 10.1038/leu.2008.365

KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia

Willemze, R.; Rodrigues, C. A.; Labopin, M.; Sanz, G.; Michel, G.; Socie, G.; Rio, B.; Sirvent, A.; Renaud, M.; Madero, L.; Mohty, M.; Ferra, C.; Garnier, F.; Loiseau, P.; Garcia, J.; Lecchi, L.; Koegler, G.; Beguin, Y.; Navarrete, C.; Devos, T.; Ionescu, I.; Boudjedir, K.; Herr, A-L; Gluckman, E.; Rocha, V.

Complex Variant t(9;22) Chromosome Translocations in Five Cases of Chronic Myeloid Leukemia

Valencia A, Cervera J, Such E, Barragán E, Bolufer P, Fuster Ó, Collado R, Martínez J, Sanz MA

[Pocket guide to invasive mycoses in onco-hematologic patients]

Bermúdez A, Carreras E, la Cámara de R, Eraso E, Fortún J, García-Ruiz JC, Guarro J, Jarque I, Marcos de Lucas E, Mayayo E, Pastor FJ, Pemán J, Pontón J, Quindós G, Salavert-Lleti M, Sanz MA, Zaragoza R

Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors

Montesinos P, Bergua JM, Vellenga E, Rayón C, Parody R, la Serna de J, León A, Esteve J, Milone G, Debén G, Rivas C, González M, Tormo M, Díaz-Mediavilla J, González JD, Negri S, Amutio E, Brunet S, Löwenberg B, Sanz MA

Single daily dose of intravenous busulfan and melphalan as a conditioning regimen for patients with multiple myeloma undergoing autologous stem cell transplantation: a phase II trial

Blanes M, la Rubia de J, Lahuerta JJ, González JD, Ribas P, Solano C, Alegre A, Sanz MA

Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

Sanz MA, Grimwade D, Tallman MS, Löwenberg B, Fenaux P, Estey EH, Naoe T, Lengfelder E, Büchner T, Döhner H, Burnett AK, Lo-Coco F

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kühne T, Ruggeri M, George JN

[Micafungin in invasive candidiasis among oncohematological patients]

Jarque I, Sanz MA

Imipenem/cilastatin with or without glycopeptide as initial antibiotic therapy for recipients of autologous stem cell transplantation: results of a Spanish multicenter study

la Rubia de J, Montesinos P, Martino R, Jarque I, Rovira M, Vazquez L, López J, Batlle M, la Cámara de R, Juliá A, Lahuerta JJ, Debén G, Díaz J, García R, Sanz MA

doi: DOI: 10.1016/j.medcli.2009.01.008

Treatment of fungal infections in patients with hematologic neoplasia

Mensa J, la Cámara de R, Carreras E, Cuenca-Estrella M, García Rodríguez JA, Gobernado M, Picazo J, Aguado JM, Sanz MA

Improved Outcome of Acute Promyelocytic Leukemia With High WBC Counts Over the Last 15 Years: The European APL Group Experience

Kelaidi C, Chevret S, de Botton S, Raffoux E, Guerci A, Thomas X, Pigneux A, Lamy T, Rigal-Huguet F, Meyer-Monard S, Chevallier P, Maloisel F, Deconinck E, Ferrant A, Fegueux N, Ifrah N, Sanz M, Dombret H, Fenaux P, Ades L

Incidence, risk factors, and outcome of cytomegalovirus infection and disease in patients receiving prophylaxis with oral valganciclovir or intravenous ganciclovir after umbilical cord blood transplantation

Montesinos P, Sanz J, Cantero S, Lorenzo I, Martín G, Saavedra S, Palau J, Romero M, Montava A, Senent L, Martínez J, Jarque I, Salavert-Lleti M, Córdoba J, Gómez L, Weiss S, Moscardó F, la Rubia de J, Larrea L, Sanz MA, Sanz GF

Impact of hematopoietic chimerism at day +14 on engraftment after unrelated donor umbilical cord blood transplantation for hematologic malignancies

Moscardó F, Sanz J, Senent L, Cantero S, la Rubia de J, Montesinos P, Planelles D, Lorenzo I, Cervera J, Palau J, Sanz MA, Sanz GF

Rapid detection of KIT mutations in core-binding factor acute myeloid leukemia using high-resolution melting analysis

Fuster Ó, Barragán E, Bolufer P, Cervera J, Larráyoz MJ, Jiménez-Velasco A, Martínez-López J, Valencia A, Moscardó F, Sanz MA

Absence of mutations in the tyrosine kinase and juxtamembrane domains of C-FMS gene in chronic myelomonocytic leukemia (CMML)

Such E, Cervera J, Valencia A, Garcia-Casado Z, Senent ML, Sanz MA, Sanz GF

Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia

Valencia A, Román-Gómez J, Cervera J, Such E, Barragán E, Bolufer P, Moscardó F, Sanz GF, Sanz MA

Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis

Montesinos P, Díaz-Mediavilla J, Debén G, Prates V, Tormo M, Rubio V, Pérez I, Fernández I, Viguria M, Rayón C, González J, la Serna de J, Esteve J, Bergua JM, Rivas C, González M, González JD, Negri S, Brunet S, Löwenberg B, Sanz MA

FLT3 inhibition as a targeted therapy for acute myeloid leukemia

Sanz M, Burnett A, Lo-Coco F, Löwenberg B

Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required

Pascual AM, Téllez N, Boscá I, Mallada J, Belenguer A, Abellán I, Sempere AP, Fernández P, Magraner MJ, Coret F, Sanz MA, Montalbán X, Casanova B

doi: 10.1111/j.1399-3062.2008.00331.x

Donor screening for hepatitis B virus infection in a cell and tissue bank

Solves P, Mirabet V, Alvarez M, Vila E, Quiles F, Villalba JV, Montoro JA, Soler MA, Roig RJ

doi: 10.2147/tcrm.s3994

Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts?

Zaragoza R, Pemán J, Salavert M, Viudes A, Solé A, Jarque I, Monte E, Romá E, Cantón E

doi: 10.1007/s10549-007-9818-y

Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families of Eastern Spain

Esteban Cardeñosa E, Bolufer Gilabert P, Palanca Suela S, Oltra Soler S, Barragán González E, Velasco Sampedro E, Chirivella González I, Segura Huerta A, Guillén Ponce C, Martínez de Dueñas E

doi: 10.1007/s10549-007-9839-6

Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family

Palanca Suela S, Esteban Cardeñosa E, Barragán González E, Oltra Soler S, de Juan Jiménez I, Chirivella González I, Segura Huerta A, Guillén Ponce C, Martínez de Dueñas E, Bolufer Gilabert P

doi: 10.1182/blood-2008-05-159632

Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid andanthracycline monochemotherapy: Long-term outcome of the LPA 99 multicenter study by thePETHEMA Group

Sanz MA1, Montesinos P, Vellenga E, Rayón C, de la Serna J, Parody R, Bergua JM, León A, Negri S, González M, Rivas C, Esteve J, Milone G, González JD, Amutio E, Brunet S, García-Laraña J, Colomer D, Calasanz MJ, Chillón C, Barragán E, Bolufer P, Lowenberg B.

doi: 10.1016/j.cryobiol.2008.07.008

Long-term storage in liquid nitrogen does not affect cell viability in cardiac valve allografts

Mirabet V, Carda C, Solves P, Novella-Maestre E, Carbonell-Uberos F, Caffarena JM, Hornero F, Montero JA, Roig RJ

doi: 10.1016/j.cca.2008.05.021

Minimal residual disease detection in acute myeloid leukemia by mutant nucleophosmin (NPM1):Comparison with WT1 gene expression

Barragán E, Pajuelo JC, Ballester S, Fuster O, Cervera J, Moscardó F, Senent L, Such E, Sanz MA, Bolufer P

doi: 10.3324/haematol.12880

Enumeration of cytomegalovirus-specific interferongamma CD8+ and CD4+ T cells early after allogeneic stem cell transplantation may identify patients at risk of active cytomegalovirus infection

Solano C, Benet I, Clari MA, Nieto J, de la Cámara R, López J, Hernández-Boluda JC, Remigia MJ, Jarque I, Calabuig ML, Garcia-Noblejas A, Alberola J, Tamarit A, Gimeno C, Navarro D

doi: 10.1111/j.1600-6143.2008.02270.x

Unexpected postmortem diagnosis of Acanthamoeba meningoencephalitis following allogeneic peripheral blood stem cell transplantation

Pemán J, Jarque I, Frasquet J, Alberola C, Salavert M, Sanz J, Gomila B, Esteban G

doi: 10.1016/j.healun.2008.03.006

Heart Transplantation in a Patient With Systemic Mastocytosis

Moro JA, Almenar L, Jarque I, Martinez-Dolz L, Hernández MD, Crespo M, Salvador A

doi: 10.2174/157488808784223096

Banking Strategies for Improving the Hematopoietic Stem Cell Content of Umbilical Cord Blood Units for Transplantation

Solves P, Mirabet V, Perales A, Carbonell-Uberos F, Roig R

doi: 10.1016/j.cryobiol.2008.02.002

Influence of volume reduction and cryopreservation methodologies on quality of thawed umbilical cord blood units for transplantation

Solves P, Mirabet V, Planelles D, Carbonell-Uberos F, Roig R

doi: 10.1038/sj.bmt.1705973

Hematopoietic transplantation from adult unrelated donors as treatment for acute myeloid leukemia

Sierra J, Martino R, Sánchez B, Piñana JL, Valcárcel D, Brunet S

doi: 10.1007/s10561-007-9048-x

Human platelet lysate enhances the proliferative activity of cultured human fibroblast-like cells from different tissues

Mirabet V, Solves P, Miñana MD, Encabo A, Carbonell-Uberos F, Blanquer A, Roig R

doi: 18426697

Cost-effectiveness analysis of the empirical antifungal strategy in oncohaematological patients [Estudio coste-efectividad de la estrategia empírica antifúngica en pacientes oncohematológicos]

Romá-Sánchez E, Poveda-Andrés JL, García-Pellicer J, Salavert-Lletí M, Jarque-Ramos I

doi: 10.1200/JCO.2007.11.1641

Sustained Remissions of High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome After Reduced-Intensity Conditioning Allogeneic Hematopoietic Transplantation: Chronic Graft-Versus-Host Disease Is the Strongest Factor Improving Survival

Valcárcel D, Martino R, Caballero D, Martin J, Ferra C, Nieto JB, Sampol A, Bernal MT, Piñana JL, Vazquez L, Ribera JM, Besalduch J, Moraleda JM, Carrera D, Brunet MS, Perez-Simón JA, Sierra J

doi: 10.1016/j.diagmicrobio.2007.07.014

Fungemia due to Candida guilliermondii in a pediatric and adult population during a 12-year period

Pemán J, Bosch M, Cantón E, Viudes A, Jarque I, Gómez-García M, García-Martínez JM, Gobernado M

Intensive chemotherapy and stem cell transplantation in myelodysplastic syndromes

Sanz, G.F., de Witte, T.

doi: 10.1002/cncr.23697

Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System

Kantarjian, Hagop; O'Brien, Susan; Ravandi, Farhad; Cortes, Jorge; Shan, Jianqin; Bennett, John M.; List, Alan; Fenaux, Pierre; Sanz, Guillermo; Issa, Jean-Pierre; Freireich, Emil J.; Garcia-Manero, Guillermo

Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model

Montesinos P, Lorenzo I, Martín G, Sanz J, Pérez-Sirvent ML, Martínez D, Ortí G, Algarra L, Martínez J, Moscardó F, de la Rubia J, Jarque I, Sanz G, Sanz MA

Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results

Ades L,? Sanz MA,2 Chevret S, Montesinos P, Chevallier P, Raffoux E, Vellenga E, Guerci A, Pigneux A, Huguet F, Rayon C, Stoppa AM, de la Serna J, Cahn JY, Meyer-Monard S, Pabst T, Thomas X, de Botton S, Parody R, Verruga J, Lamy T, Vekhoff A, Negri S, Ifrah N, Dombret H, Ferrant A, Bron D, Degos L, Fenaux P

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, Aledort LM, George JN, Kessler CM, Sanz MA, Liebman HA, Slovick FT, de Wolf JThM, Bourgeois E, Guthrie TH, Newland A, Wasser JS, Hamburg SI, Grande C, Lefrère F, Lichtin AE, Tarantino MD, Terebelo HR, Viallard JF, Cuevas FJ, Go RS, Henry DH, Redner RL, Rice L, Schipperus MR, Guo DM, Nichol JL

Update on pulmonary infections in patients with hematologic malignancies and hematopoietic stem cell recipients

Sanz MA, de la Cámara R, Jarque I, López J, Madero L, Ruiz I, Vázquez L, Vallejo C

Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin

de la Serna J, Montesinos P, Vellenga E, Rayón C, Parody R, León A, Esteve J, Bergua JM, Milone G, Debén G, Rivas C, González M, Tormo M, Díaz-Mediavilla J, González JD, Negri S, Amutio E, Brunet S, Lowenberg B, Sanz MA

Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the pediatric-based protocol PETHEMA ALL-96

Ribera JM, Oriol A, Sanz MA, Tormo M, Fernandez-Abellan P, del Potro E, Abella E, Bueno J, Parody R, Bastida P, Grande C, Heras I, Bethencourt C, Feliu E, Ortega JJ

Follow-up of healthy donors receiving G-CSF for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry

De la Rubia J, De Arriba F, Arbona C, Pascual MJ, Zamora C, Insunza A, Martínez D, Paniagua C, Díaz MA, Sanz MA

Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy

Cilloni D, Messa F, Arruga F, Defilippi Ll, Gottardi E, Fava M, Carturan S, Catalano R, Bracco E, Messa E, Nicoli P, Diverio D, Sanz MA, Martinelli G, Lo-Coco F, Saglio G

Acute promyelocytic leukemia: Recent advances in diagnosis and management

Lo-Coco F, Ammatuna E, Montesinos P, Sanz MA

Lack of RPS14 promoter aberrant methylation supports the haploinsufficiency model for the 5q- syndrome

Valencia A, Cervera J, Such E, Sanz MA, Sanz GF

Four new cases of therapy-related acute promyelocytic leukemia after Mitoxantrone

Bosca I, Pascual AM, Casanova B, Coret F, Sanz MA

Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis

Hasan SK, Mays AN, Ottone T, Ledda A, La Nasa G, Cattaneo Ch, Borlenghi E, Melillo L, Montefusco E, Cervera J, Stephen C, Satchi G, Lennard A, Libura M, Byl JA, Osheroff N, Amadori S, Felix CA, Voso MT, Sperr WR, Esteve J, Sanz MA, Grimwade D, Lo-Coco F

Guía clínica para el tratamiento de las infecciones causadas por Estafilococo Aureus meticilin-resistente

Mensa J, Barberán J, Llinares P, Picazo J, Bouza E, Alvarez-Lerma F, Borges M, Serrano R, León C, Guirao X, Arias J, Carreras E, Sanz M, García-Rodríguez J

Momento actual de las trombopoyetinas

Romero M, Jarque I, Palau J, Sanz MA

doi: 10.1111/j.1537-2995.2008.01753.x

A broken cord blood bag: placing the unit in a sterile zip-lock bag before thawing prevents catastrophic events

Larrea, Luis; Sanz, Guillermo; Solves, Pilar; Mirabet, Vicente; Roig, Roberto

doi: 10.3332/ecancer.2008.118

The effects of continued azacitidine treatment cycles on response in higher risk patients with myelodysplastic syndromes: an update.

Silverman, L R; Fenaux, P; Mufti, G J; Santini, V; Hellstrom-Lindberg, E; Gattermann, N; Sanz, G; List, A F; Gore, S D; Seymour, J F; Backstrom, J; McKenzie, D; Beach, C L

doi: 10.3332/ecancer.2008.121

Azacitidine prolongs overall survival and reduces infections and hospitalizations in patients with WHO-defined acute myeloid leukaemia compared with conventional care regimens: an update.

Fenaux, P; Mufti, G J; Hellstrom-Lindberg, E; Santini, V; Gattermann, N; Sanz, G; List, A F; Gore, S D; Seymour, J F; Backstrom, J; Zimmerman, L; McKenzie, D; Beach, C L; Silverman, L B

doi: 10.3324/haematol.13012

Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-

Mallo, Mar; Arenillas, Leonor; Espinet, Blanca; Salido, Marta; Maria Hernandez, Jesus; Lumbreras, Eva; del Rey, Monica; Arranz, Eva; Ramiro, Soraya; Font, Patricia; Gonzalez, Olga; Renedo, Monica; Cervera, Jose; Such, Esperanza; Sanz, Guillermo F.; Luno, Elisa; Sanzo, Carmen; Gonzalez, Miriam; Jose Calasanz, Maria; Mayans, Jose; Garcia-Ballesteros, Carlos; Amigo, Victoria; Collado, Rosa; Oliver, Isabel; Carbonell, Felix; Bureo, Encarna; Insunza, Andres; Yanez, Lucrecia; Jose Muruzabal, Maria; Gomez-Beltran, Elena; Andreu, Rafael; Leon, Pilar; Gomez, Valle; Sanz, Angeles; Casasola, Natalia; Moreno, Esperanza; Alegre, Adrian; Luisa Martin, Maria; Pedro, Carmen; Serrano, Sergi; Florensa, Lourdes; Sole, Francesc

doi: 10.1007/s00277-008-0449-0

Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes

Giagounidis, Aristoteles; Fenaux, Pierre; Mufti, Ghulam J.; Muus, Petra; Platzbecker, Uwe; Sanz, Guillermo; Cripe, Larry; Von Lilienfeld-Toal, Marie; Wells, Richard A.

doi: 10.3324/haematol.11575

Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model

Montesinos, Pau; Lorenzo, Ignacio; Martin, Guillermo; Sanz, Jaime; Perez-Sirvent, Maria Luz; Martinez, David; Orti, Guillermo; Algarra, Lorenzo; Martinez, Jesus; Moscardo, Federico; de la Rubia, Javier; Jarque, Isidro; Sanz, Guillermo; Sanz, Miguel A.

doi: 10.3324/haematol.13405

Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts

Mufti, Ghulam J.; Bennett, John M.; Goasguen, Jean; Bain, Barbara J.; Baumann, Irith; Brunning, Richard; Cazzola, Mario; Fenaux, Pierre; Germing, Ulrich; Hellstrom-Lindberg, Eva; Jinnai, Itsuro; Manabe, Atsushi; Matsuda, Akira; Niemeyer, Charlotte M.; Sanz, Guillermo; Tomonaga, Masao; Vallespi, Teresa; Yoshimi, Ayami

doi: 10.1111/j.1651-2227.2007.00549.x

Results of a programme to evaluate babies after umbilical cord blood donation

Solves P, Mirabet V, Perales A, Roig R

doi: 10.1111/j.1600-6143.2007.01964.x

Bloodstream infections among transplant recipients: Results of a nationwide surveillance in Spain

Moreno A, Cervera C, Gavaldá J, Rovira M, de la Cámara R, Jarque I, Montejo M, de la Torre-Cisneros J, Miguel Cisneros J, Fortún J, López-Medrano F, Gurguí M, Muñoz P, Ramos A, Carratalá J

doi: 10.1016/j.trim.2007.05.002

Impact of HLA class I and class II DNA high-resolution HLA typing on clinical outcome in adult unrelated stem cell transplantation after in vivo T-cell depletion with alemtuzumab

Perz JB, Szydlo R, Sergeant R, Sanz J, O'Shea D, Khan T, Davey N, Loaiza S, Davis J, Apperley JF, Olavarria E

doi: 10.1157/13111706

Selección de donantes y recogida de las unidades en un banco de sangre de cordón umbilical | [Donors Selection and Retrieval of Units in an Umbilical Cord Blood Bank]

Solves Alcaina P, Perales Marín A, Mirabet Lis V, Brik Spinelli M, Soler García MA, Roig Oltra R

doi: 10.1016/s0210-4806(07)73737-3

Prognostic factors for disease progression in patients with renal cell carcinoma | [Análisis delos factores pronósticos de progresión tumoral en el adenocarcinoma renal]

Budía Alba A, Gómez Pérez L, Bango V, Ruiz-Cerdá JI, Sempere A, Queipo JA, Jiménez Cruz JF

doi: 10.1016/j.leukres.2006.10.002

The GST deletions and NQO1*2 polymorphism confers interindividual variability of response totreatment in patients with acute myeloid leukemia

Barragán E, Collado M, Cervera C, Martín G, Bolufer P, Sanz MA

doi: 10.1532/IJH97.E0704

Results of Compassionate Therapy with Intrathecal Depot Liposomal Cytarabine in Acute Myeloid Leukemia Meningeosis

Sancho JM, Deben G, Parker A, Piñana JL, Bolam S, Sánchez-García E, Giménez E, Pascual T, Fernández-Abellán P, Palomera L, Ribera JM

doi: 10.1016/j.freeradbiomed.2007.02.033

Targeting lipoic acid to mitochondria: Synthesis and characterization of a triphenylphosphonium-conjugated α-lipoyl derivative

Brown SE, Ross MF, Sanjuan-Pla A, Manas AR, Smith RA, Murphy MP

doi: 10.1111/j.1365-3148.2007.00740.x

Stress factors and umbilical cord blood banking

Solves P, Perales A, Mirabet V, Roig R.

doi: 10.1016/j.cancergencyto.2006.11.019

MLL amplification in acute myeloid leukemia

Pajuelo-Gámez JC1, Cervera J, García-Casado Z, Mena-Durán AV, Valencia A, Barragán E, Such E, Bolufer P, Sanz MA

doi: 10.1111/j.1537-2995.2006.01149.x

CD34+ cell content for selecting umbilical cord blood units for cryopreservation

Solves P, Carbonell-Uberos F, Mirabet V, Roig R

doi: 10.1111/j.1537-2995.2007.01103.x

The functional immaturity of dendritic cells can be relevant to increased tolerance associated with cord blood transplantation

Encabo A, Solves P, Carbonell-Uberos F, Miñana MD

Cell and tissue bank. Experience of Valencia, Spain

Mirabet-Lis V, Solves, P, Larrea-González L.R., Roig-Oltra, R.J.

doi: ISSN 0213-8573

Treatment of agressive lymphomas in the elderly | [Manejo del linfoma agresivodel paciente anciano]

Gómez Codina, J. Jarque Ramos, I.

doi: 10.1038/sj.bmt.1705544

LACE-conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin’s lymphoma: treatment outcome and risk factor analysis in 67 patients from a single centre

Perz JB, Giles C, Szydlo R, O'Shea D, Sanz J, Chaidos A, Wagner S, Davis J, Loaiza S, Marin D, Apperley J, Olavarria E, Rahemtulla A, Lampert I, Naresh K, Samson D, MacDonald D, Kanfer EJ

doi: 10.1111/j.1365-2141.2007.06759.x

Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes

Peggs, Karl S.; Sureda, Anna; Qian, Wendi; Caballero, Dolores; Hunter, Ann; Urbano-Ispizua, Alvaro; Cavet, James; Ribera, Josep M.; Parker, Anne; Canales, Miguel; Mahendra, Premini; Garcia-Conde, Javier; Milligan, Donald; Sanz, Guillermo; Thomson, Kirsty; Arranz, Reyes; Goldstone, Anthony H.; Alvarez, Ivan; Linch, David C.; Sierra, Jorge; Mackinnon, Stephen

Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia

Sancho JM, Ribera JM, Xicoy B, Morgades M, Oriol A, Tormo M, Potro ED, Deben G, Abella E, Bethencourt C, Ortin X, Brunet S, Ortega-Rivas F, Novo A, Lopez R, Hernandez-Rivas JM, Sanz MA, Feliu E

Profile of polymorphisms of drug-metabolizing enzymes and the risk of therapy-related leukaemia

Bolufer P, Collado M, Barragán E, Calasanz MJ, Colomer D, Tormo M, González M, Brunet S, Batlle M, Cervera J, Sanz MA

Outcome of patients with acute promyelocytic leukemia failing to treatment with all-trans retinoic acid and anthracycline-based chemotherapy. Analysis of molecular and hematological relapses of patients from PETHEMA protocols LPA96 and LPA99

Esteve J, Escoda L, Martín G, Díaz-Mediavilla J, González M, Rivas C, Rubio V, Brunet S, Tomás JF, Tormo M, González-San Miguel JD, Sayas MJ, Sánchez Godoy P, Colomer D, Bolufer P, Sanz MA

The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the riskof developing acute leukemia

Bolufer P, Collado M, Barragán E, Cervera J, Calasanz MJ, Colomer D, Román J, Sanz MA

doi: 10.3324/haematol.11226

Current treatment of acute promyelocytic leukemia

Lo-Coco F, Ammatuna E, Sanz MA

Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the atra era: a survey of the european cooperative group for blood and marrow transplantation

Sanz MA, Labopin M, Gorin NC, de la Rubia J, Arcese W, Meloni G, Bacigalupo A, Alessandrino P, Carreras E, Iriondo A, Novitzky N, Jacobs P, Bandini G, Lo-Coco F, Frassoni F, Rocha V

Update on bacterial infections in immunocompromised patients

Mensa J, Garau J, Jarque I, Luque P, Pahissa A, Portilla J, Salavert M, Sanz MA, Solé A, de la Cámara R

Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients

Sanz J, Arriaga F, Montesinos P, Ortí G, Lorenzo I, Cantero S, Puig N, Moscardó F, de la Rubia J, Sanz G, Sanz MA

A study of incidence and characteristics of infections in 476 patients from a single center undergoing autologous blood stem cell transplantation

Puig N, de la Rubia J, Jarque I, Salavert M, Montesinos P, Sanz J, Martín G, Blanes M, Moscardó F, Cantero S, Lorenzo I, Sanz GF, Moscardó J, Martínez JA, Jiménez C, Sanz MA

Indicaciones actuales de voriconazol en pacientes onco-hematológicos

Jarque I, Sanz MA

Could ATRA/Idarubicin treatment of acute promyelocytic leukemia induce the appearance of new clonal cytogenetic abnormalities in patients in complete remission?

Mallo M, Salido M, Espinet B, Cervera J, Canellas A, Pajuelo JC, Pedro C, Florensa L, Sanz MA, Sole F

Bleeding and thrombosis in acute leukemia: What does the future of therapy look like?

Rickles FR, Falanga A, Montesinos P, Sanz MA, Brenner B, Barbui T

Characteristics and risk factors for pneumonia in patients with hematological malignancies developing fever after autologous blood stem cell transplantation

Puig N, de la Rubia J, Jarque I, Salavert M, Moscardó F, Sanz J, Lorenzo I, Montesinos P, Martín G, Martínez JA, Sanz GF, Blanes M, Sanz MA

Utilidad de las fluoroquinolonas en la profilaxis y el tratamiento de las infecciones del paciente hematológico

Jarque I, Sanz MA

doi: 10.1016/j.bbmt.2006.06.010

Encouraging Results with Inolimomab (Anti-IL-2 Receptor) as Treatment for Refractory Acute Graft-versus-Host Disease

Piñana JL, Valcárcel D, Martino R, Moreno ME, Sureda A, Briones J, Brunet S, Sierra J

doi: 10.1016/j.cancergencyto.2006.05.011

High-level amplification of the RUNX1 gene in two cases of childhood acute lymphoblasticleukemia

García-Casado Z1, Cervera J, Verdeguer A, Tasso M, Valencia A, Pajuelo JC, Mena-Duran AV, Barragán E, Blanes M, Bolufer P, Sanz MA.

doi: 10.1157/13094277

Changing epidemiological aspects of candidemia and their clinical and therapeutic implications | [Los aspectos epidemiológicos cambiantes de la candidemia y sus implicaciones clinicoterapéuticas]

Salavert Lletí M, Jarque Ramos I, Pemán García J

doi: 10.1016/j.cancergencyto.2006.02.021

New translocations in a case of atypical B-cell chronic lymphocytic leukemia: involvement of ATM,MLL, and TP53 genes

Collado R, Hueso J, Cabello AI, Oliver I, Egea M, Orero M, Miguel-Sosa A, Cigudosa JC, Benítez J, Barragán E, Carbonell F.

doi: 10.1016/j.cca.2005.12.041

A t(17;20)(q21;q12) masking a variant t(15;17)(q22;q21) in a patient with acute promyelocyticleukemia

García-Casado Z, Cervera J, Valencia A, Pajuelo JC, Mena-Duran AV, Barragán E, Bolufer P, Sanz M

doi: 10.1016/j.cca.2005.12.041

Molecular detection of Spanish deltabeta-thalassemia associated with beta-thalassemia identified during prenatal diagnosis

Barragan E1, Bolufer P, Perez ML, Prieto F, Sanz MA.

doi: 10.2147/tcrm.2006.2.2.129

Voriconazole in the management of nosocomial invasive fungal infections

Pemán J, Salavert M, Cantón E, Jarque I, Romá E, Zaragoza R, Viudes A, Gobernado M